Moreover, serum sE-CAD/KLRG1 axis may inhibit KLRG1+ cytotoxic T-cells and NK cells function in the peripheral blood, probably suppressing their cytokine secretion and proliferation both in the periphery and in the tumor microenvironment. Here, KLRG1 is linked to neoplasm.